Vigil Neuroscience
Edit

Vigil Neuroscience

https://www.vigilneuro.com/
Last activity: 29.02.2024
Categories: ToolsPublicDrugDevelopment
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.
Followers
795
Mentions
5
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $215M
Founded date: 2020

Investors 4

Funding Rounds 3

DateSeriesAmountInvestors
16.08.2022-$75M-
18.08.2021Series B$90M-
17.12.2020Series A$50M-

Mentions in press and media 5

DateTitleDescriptionSource
16.08.2022Vigil Neuroscience Announces $75 Million Private Placement F...-lightstone...
12.08.2022Vigil Neuroscience Announces $75 Million Private Placement F...CAMBRIDGE, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clini...globenewsw...
18.08.2021Vigil Neuroscience Completes $90M Series B CAMBRIDGE, MA, Vigil Neuroscience, a biotechnology company announced the completion of a $90 milli...vcnewsdail...
08.12.2020Vigil Neuroscience Launches $50 Million Series ACAMBRIDGE, Mass.--(BUSINESS WIRE)--Vigil Neuroscience, a new biotechnology company harnessing the po...citybizlis...
08.12.2020Neurodegeneration startup launches with $50M, Amgen assetsEight years after Atlas Venture began probing a group of nervous system cells and their effects in A...bizjournal...

Reviews 0

Sign up to leave a review

Sign up Log In